Overview of This Study:

The study involved four major activities in estimating the current size of the transplant diagnostics market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2531061

Transplant Diagnostics Market, by Region,2023(USD billion)

The growth of this market is mainly driven by increasing number of transplantation procedures, technological advancements in transplant diagnostics, increasing public and private funding for targeted research activities, and increasing burden on infectious diseases driving growth of transplant diagnostics market.

Recent Developments in Transplant Diagnostics Market

In August 2019, Care Dx (US) acquired XynManagement (US) to simplify transplant quality tracking and waitlist management.
In March 2019, Hologic established a learning and experience center in Zaventem (Belgium) to create awareness among customers, healthcare professionals, and employees across Europe, the Middle East, and Africa about the benefits of diagnostic products, including transplant diagnostic products.
In February 2019, Care Dx (US) launched the Allosure for lung transplants.
In January 2018, F. Hoffman-LA Roche Limited (Switzerland) launched the Cobas Plasma Separation Card.
Market Restraints:

The high cost of procedures associated with PCR and NGS diagnostic instruments is one of the most significant. As a result, market growth may be hampered in the long run. The cost of medical equipment is one element that may provide a challenge to critical transplant diagnosis device vendors. The widening gap between organ donors and transplantation operations is a significant concern for market players.

Global Market Players

Some prominent players in the transplant diagnostics market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), and Immucor, Inc. (US).

Different Growth Strategies Adopted by Them:

Market Competitive Analysis:

Top 10 players in this industry profiled in the report include. These players have adopted various strategies including expansions, mergers & acquisitions, joint ventures, new product launches, and collaborations to gain a strong position in the industry.

Bio-Rad Laboratories, Inc. is the leading player in the global transplant diagnostics market. The company has a broad range of automated instruments for antibody screening and analysis, semi-automated systems for serological assays, standalone systems & reagents for molecular and non-molecular assay procedures, including transplant diagnostic products. The company has a keen focus on leveraging its core technologies by introducing product line extensions as well as new product offerings. GE Healthcare also seeks strategic partners to develop products.

F. Hoffman-La Roche Ltd. is one of the major players in the market, as of 2019. The company has a broad product portfolio of transplant diagnostic products, including state-of-the-art instruments such as Rotor-Gene Q2plex System, QIAsymphony RGQ System, and EZ1 Advanced XL System and reagents such as GeneRead DNA Library Q Kit and RT2 qPCR Primer Assay for Human HLA-A.

QIAGEN has a strong geographic presence across the US, Canada, Brazil, Mexico, Germany, the UK, Switzerland, France, Japan, Australia, Canada, and Italy. QIAGEN collaborated with BioTeam (US), 10X Genomics (US), Seegene (South Korea), and Hitachi (Japan) to strengthen its R&D capabilities in the transplant diagnostics market

Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=2531061

Major Revenue Growth Expectations:

The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%.